Detection of Streptococcus pyogenes by use of Illumigene group A Streptococcus assay

Amanda M Henson1, Donna Carter, Kathleen Todd

  • 1Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.

Insights

The Illumigene group A Streptococcus assay demonstrated high sensitivity and specificity for detecting strep throat infections. This rapid diagnostic tool offers a reliable alternative to traditional culture and PCR methods.

Area of Science:

  • Microbiology
  • Clinical Diagnostics
  • Infectious Diseases

Background:

  • Group A Streptococcus (GAS) is a significant bacterial pathogen causing pharyngitis.
  • Accurate and rapid diagnosis of GAS is crucial for effective treatment and preventing complications.
  • Existing diagnostic methods like culture and PCR have limitations in terms of speed or complexity.

Purpose of the Study:

  • To evaluate the performance of the Illumigene group A Streptococcus assay.
  • To compare the assay's accuracy against standard culture and PCR methods.
  • To assess the clinical utility of a rapid diagnostic test for GAS.

Main Methods:

  • The Illumigene assay was evaluated using 437 consecutive throat swabs compared to culture.
  • A subset of 161 samples was directly compared between the Illumigene assay and PCR.
  • Performance metrics including sensitivity and specificity were calculated.

Main Results:

  • The Illumigene assay showed high sensitivity (100%) compared to both culture and PCR.
  • High specificity (99.2%) was observed when compared to PCR.
  • The assay was noted to be rapid and easy to perform.
  • Antibiotic resistance data indicated 8.8% erythromycin and 6.9% clindamycin resistance.

Conclusions:

  • The Illumigene assay is a highly sensitive and specific diagnostic tool for group A Streptococcus.
  • Its rapid and user-friendly nature makes it a valuable option for clinical settings.
  • The assay provides accurate detection of GAS, aiding timely patient management.

Related Concept Videos